Vor Biopharma
(NASDAQ) VOR
Vor Biopharma Financials at a Glance
Market Cap
$563.42M
Revenue (TTM)
$0.00
Net Income (TTM)
$2.45B
EPS (TTM)
$-386.85
P/E Ratio
-0.04
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$13.60
Volume
49,866
Open
$12.70
Price
$13.60
Volume
49,866
Open
$12.70
Previous Close
$13.60
Daily Range
$12.67 - $14.18
52-Week Range
$2.62 - $65.80
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$13.60
Volume
49,866
Open
$12.70
Previous Close
$13.60
Daily Range
$12.67 - $14.18
52-Week Range
$2.62 - $65.80
VOR News
VOR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vor Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
159
CEO
Jean-Paul Kress, MD
Website
www.vorbio.comHeadquarters
Cambridge, MA 02140, US
VOR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-125%
Return on Capital
-2%
Return on Assets
-14%
Earnings Yield
-25.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$563.42M
Shares Outstanding
41.52M
Volume
49.87K
Short Interest
0.00%
Avg. Volume
919.41K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$121.19M
EBITDA
$117.66M
Operating Cash Flow
$99.66M
Capital Expenditure
$229.00K
Free Cash Flow
$99.89M
Cash & ST Invst.
$91.93M
Total Debt
$31.83M
Vor Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$563.42M
N/A
Market Cap/Employee
$3.54M
N/A
Employees
159
N/A
Net Income
$812.68M
-2848.9%
EBITDA
$812.68M
-2837.9%
Quarterly Fundamentals
Net Cash
$167.40M
+458.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.81M
-90.2%
Short Term Debt
$252.00K
-93.9%
Return on Assets
-13.90%
N/A
Return on Invested Capital
-2.33%
N/A
Free Cash Flow
$53.91M
-131.2%
Operating Cash Flow
$53.66M
-130.5%